Doctor Ian Campbell lead pioneering research on ketogenic metabolic therapy for bipolar disorder. University of Edinburghone British major research center
San Mateo, California, December 7, 2022 /PRNewswire/ — Today, Baszucky Brain Research Fund I am proud to announce my Ph.D. Ian Campbell as the first metabolic psychiatric researcher. for the duration of the four-year fellowship; and $380,000, Dr. Campbell plans to expand the university’s current research program on ketogenic metabolic therapy for bipolar disorder to include mechanically controlled clinical trials. His work also focuses on raising awareness through podcasting and online content, and empowering advocates within the bipolar disorder community to encourage participation in research.
Doctor Ian Campbell One of the few scientists studying bipolar disorder and living with it. After personally putting his illness into remission using ketogenic therapy, he dedicated his career to researching mental health and promoting the emerging field of metabolic psychiatry.Dr. Campbell earned his Ph.D. did.in Global Health from University of Edinburgh, and nine peer-reviewed papers on mental health and public engagement. He is co-principal investigator of the first European trial of ketogenic therapy for bipolar disorder.Co-sponsored bipolar casta podcast featuring individuals using ketogenic therapy to manage bipolar disorder, Questionnaire survey of the lived experience of ketogenic therapy for bipolar disorder.
“Dr. Campbell and colleagues University of Edinburgh We are well positioned to advance the understanding and treatment of bipolar disorder as a metabolic disorder of the brain.” Jan Ellison BassWookiefounded the Baszucki Brain Research Fund with her husband, the founder and CEO of Roblox David Baszuckey“Pioneering research already underway at the University is investigating ketogenic metabolic therapy that has helped my son as a safe, effective and potentially transformative intervention for bipolar disorder.”
“People with bipolar disorder live with a significant metabolic load and are at high risk of developing type 2 diabetes. Ian Campbell“Our program is unique in its approach to conducting mechanistic clinical trials of ketogenic metabolic therapies that show promise in addressing both psychiatric symptoms and metabolic dysfunction.”
The Baszucki Brain Research Fund plans to sponsor additional fellowships in metabolic psychiatry in the coming years. For more information on the Baszucki Brain Research Fund’s commitment to mental health, please visit: https://baszuckigroup.com/our-work/metabolism-mental-health/.
About Baszucky Brain Research Fund
Part of the Baszucki Brain Research Fund bass zuckey groupwas launched in 2020 by the founder and CEO of Roblox David Baszuckey and best-selling author Jan Ellison BaszuckeyThe foundation invests in innovative science and technology to advance the prevention and treatment of bipolar disorder and other mental health conditions. It aims to combat stigma by promoting research and advances in clinical care focused on metabolic neuroscience, metabolic psychiatry, and ketogenic interventions for mental health.
Source Baszucki Group